General Information of the Protein
Protein ID
PT03899
Protein Name
High affinity choline transporter 1
Secondarily
Protein Name
Hemicholinium-3-sensitive choline transporter
Solute carrier family 5 member 7
Gene Name
SLC5A7
Secondarily
Gene Name
CHT1
Sequence
MAFHVEGLIAIIVFYLLILLVGIWAAWRTKNSGSAEERSEAIIVGGRDIGLLVGGFTMTATWVGGGYINGTAEAVYVPGYGLAWAQAPIGYSLSLILGGLFFAKPMRSKGYVTMLDPFQQIYGKRMGGLLFIPALMGEMFWAAAIFSALGATISVIIDVDMHISVIISALIATLYTLVGGLYSVAYTDVVQLFCIFVGLWISVPFALSHPAVADIGFTAVHAKYQKPWLGTVDSSEVYSWLDSFLLLMLGGIPWQAYFQRVLSSSSATYAQVLSFLAAFGCLVMAIPAILIGAIGASTDWNQTAYGLPDPKTTEEADMILPIVLQYLCPVYISFFGLGAVSAAVMSSADSSILSASSMFARNIYQLSFRQNASDKEIVWVMRITVFVFGASATAMALLTKTVYGLWYLSSDLVYIVIFPQLLCVLFVKGTNTYGAVAGYVSGLFLRITGGEPYLYLQPLIFYPGYYPDDNGIYNQKFPFKTLAMVTSFLTNICISYLAKYLFESGTLPPKLDVFDAVVARHSEENMDKTILVKNENIKLDELALVKPRQSMTLSSTFTNKEAFLDVDSSPEGSGTEDNLQ
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Transporter
>
Electrochemical transporter
>
SLC superfamily of solute carriers
>
SLC05 family of sodium-dependent glucose transporters
Function
High-affinity Na(+)-coupled choline transmembrane symporter (PubMed:11027560, PubMed:11068039, PubMed:12969261, PubMed:17005849, PubMed:23141292, PubMed:23132865, PubMed:12237312, PubMed:27569547). Functions as an electrogenic, voltage-dependent transporter with variable charge/choline stoichiometry (PubMed:17005849). Choline uptake and choline-induced current is also Cl(-)-dependent where Cl(-) is likely a regulatory ion rather than cotransported ion (PubMed:11068039, PubMed:17005849, PubMed:12237312). Plays a critical role in acetylcholine (ACh) synthesis by taking up the substrate choline from the synaptic cleft into the presynaptic nerve terminals after neurotransmitter release (PubMed:27569547). SLC5A7/CHT1-mediated choline high-affinity transport in cholinergic neurons is the rate-limiting step for production of ACh, thereby facilitating communication by subsequent action potentials (PubMed:11027560). Localized predominantly in presynaptic terminal intracellular organelles, and translocated to the plasma membrane in active form in response to neuronal activity (PubMed:12969261, PubMed:15953352).
    Show/Hide
Uniprot ID
Primary ID:
Q9GZV3

Secondarily ID:
Q53TF2
    Show/Hide
HGNC ID
HGNC:14025
Subcellular Location
Presynaptic cell membrane
Cell projection
Axon
Early endosome membrane
Cytoplasmic vesicle
Secretory vesicle
Synaptic vesicle membrane
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000006 , HEK293
Compound ID Compound Name Compound Formula
CP0052187
4-methoxy-3-(1-methylpiperidin-4-yl)oxy-N-[(3-propan-2-yl-1,2-oxazol-5-yl)methyl]benzamide
   Show/Hide
C21H29N3O4
 3
1
IC50 = 72 nM
   TI
   LI
   LO
   TS
2
IC50 = 90 nM
   TI
   LI
   LO
   TS
3
IC50 = 270 nM
   TI
   LI
   LO
   TS
CP0071979
4-methoxy-N-[(3-propan-2-yl-1,2-oxazol-5-yl)methyl]-3-(1-propan-2-ylpiperidin-4-yl)oxybenzamide
   Show/Hide
C23H33N3O4
 2
1
IC50 = 100 nM
   TI
   LI
   LO
   TS
2
IC50 = 240 nM
   TI
   LI
   LO
   TS
CP0091214
4-chloro-3-(1-methylpiperidin-4-yl)oxy-N-[(3-propan-2-yl-1,2-oxazol-5-yl)methyl]benzamide
   Show/Hide
C20H26ClN3O3
 1
1
IC50 = 270 nM
   TI
   LI
   LO
   TS
CP0399368
4-fluoro-3-(1-methylpiperidin-4-yl)oxy-N-[(3-propan-2-yl-1,2-oxazol-5-yl)methyl]benzamide
   Show/Hide
C20H26FN3O3
 1
1
IC50 = 467 nM
   TI
   LI
   LO
   TS
CP0052185
4-methoxy-3-(2-piperidin-1-ylethoxy)-N-[(3-propan-2-yl-1,2-oxazol-5-yl)methyl]benzamide
   Show/Hide
C22H31N3O4
 2
1
IC50 = 530 nM
   TI
   LI
   LO
   TS
2
IC50 = 760 nM
   TI
   LI
   LO
   TS
CP0523221
MLS001100779
   Show/Hide
C22H31N3O4
 1
1
IC50 = 600 nM
   TI
   LI
   LO
   TS
CP0408990
3-(1-methylpiperidin-4-yl)oxy-N-[(3-propan-2-yl-1,2-oxazol-5-yl)methyl]benzamide
   Show/Hide
C20H27N3O3
 1
1
IC50 = 640 nM
   TI
   LI
   LO
   TS
CP0432592
MLS001126544
   Show/Hide
C22H31N3O3S
 1
1
IC50 = 760 nM
   TI
   LI
   LO
   TS
CP0093046
N-[(1-ethyl-3,5-dimethylpyrazol-4-yl)methyl]-4-methoxy-3-(1-propan-2-ylpiperidin-4-yl)oxybenzamide
   Show/Hide
C24H36N4O3
 2
1
IC50 = 910 nM
   TI
   LI
   LO
   TS
2
IC50 = 1580 nM
   TI
   LI
   LO
   TS
CP0523220
4-methoxy-N-[(4-methyl-1,3-thiazol-2-yl)methyl]-3-(1-propan-2-ylpiperidin-4-yl)oxybenzamide
   Show/Hide
C21H29N3O3S
 2
1
IC50 = 1020 nM
   TI
   LI
   LO
   TS
2
IC50 = 3480 nM
   TI
   LI
   LO
   TS
CP0432646
4-methoxy-3-(1-methylpiperidin-3-yl)oxy-N-[(3-propan-2-yl-1,2-oxazol-5-yl)methyl]benzamide
   Show/Hide
C21H29N3O4
 2
1
IC50 = 1250 nM
   TI
   LI
   LO
   TS
2
IC50 = 4540 nM
   TI
   LI
   LO
   TS
CP0523186
MLS000733239
   Show/Hide
C26H29N3O2
 1
1
IC50 = 1260 nM
   TI
   LI
   LO
   TS
CP0379119
4-methoxy-3-(1-propan-2-ylpiperidin-4-yl)oxy-N-(2-pyrrolidin-1-ylethyl)benzamide
   Show/Hide
C22H35N3O3
 2
1
IC50 = 1560 nM
   TI
   LI
   LO
   TS
2
IC50 = 2130 nM
   TI
   LI
   LO
   TS
CP0239947
4-methoxy-N-[(2-methyl-1,3-thiazol-4-yl)methyl]-3-(1-propan-2-ylpiperidin-4-yl)oxybenzamide
   Show/Hide
C21H29N3O3S
 2
1
IC50 = 1640 nM
   TI
   LI
   LO
   TS
2
IC50 = 4930 nM
   TI
   LI
   LO
   TS
CP0068994
4-methoxy-3-(1-propan-2-ylpiperidin-4-yl)oxy-N-(1-pyridin-2-ylpropan-2-yl)benzamide
   Show/Hide
C24H33N3O3
 2
1
IC50 = 1730 nM
   TI
   LI
   LO
   TS
2
IC50 = 4120 nM
   TI
   LI
   LO
   TS
CP0379013
4-methoxy-3-(2-morpholin-4-ylethoxy)-N-[(3-propan-2-yl-1,2-oxazol-5-yl)methyl]benzamide
   Show/Hide
C21H29N3O5
 2
1
IC50 = 1770 nM
   TI
   LI
   LO
   TS
2
IC50 = 6120 nM
   TI
   LI
   LO
   TS
CP0534056
N-[(3-propan-2-yl-1,2-oxazol-5-yl)methyl]-3-(1-propan-2-ylpiperidin-4-yl)oxybenzamide
   Show/Hide
C22H31N3O3
 1
1
IC50 = 1840 nM
   TI
   LI
   LO
   TS
CP0468988
N-[(1-ethylpyrazol-4-yl)methyl]-4-methoxy-3-(1-propan-2-ylpiperidin-4-yl)oxybenzamide
   Show/Hide
C22H32N4O3
 2
1
IC50 = 1850 nM
   TI
   LI
   LO
   TS
2
IC50 = 9270 nM
   TI
   LI
   LO
   TS
CP0379120
N-[(1,5-dimethylpyrazol-3-yl)methyl]-4-methoxy-3-(1-propan-2-ylpiperidin-4-yl)oxybenzamide
   Show/Hide
C22H32N4O3
 2
1
IC50 = 2510 nM
   TI
   LI
   LO
   TS
2
IC50 = 8090 nM
   TI
   LI
   LO
   TS
CP0413202
MLS001082585
   Show/Hide
C24H36N2O3
 1
1
IC50 = 3160 nM
   TI
   LI
   LO
   TS
CP0534057
4-cyano-3-(1-methylpiperidin-4-yl)oxy-N-[(3-propan-2-yl-1,2-oxazol-5-yl)methyl]benzamide
   Show/Hide
C21H26N4O3
 1
1
IC50 = 3350 nM
   TI
   LI
   LO
   TS
CP0418546
MLS001122453
   Show/Hide
C25H32N2O3
 1
1
IC50 = 3360 nM
   TI
   LI
   LO
   TS
CP0504584
MLS001101393
   Show/Hide
C23H30N2O2
 1
1
IC50 = 4220 nM
   TI
   LI
   LO
   TS
CP0523222
3-[(1-isopropyl-4-piperidyl)oxy]-4-methoxy-N-(1-methyl-2-pyrazin-2-yl-ethyl)benzamide
   Show/Hide
C23H32N4O3
 1
1
IC50 = 4470 nM
   TI
   LI
   LO
   TS
CP0408992
3-(1-methylpiperidin-4-yl)oxy-N-[(3-propan-2-yl-1,2-oxazol-5-yl)methyl]-4-(trifluoromethyl)benzamide
   Show/Hide
C21H26F3N3O3
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
Clinical Information about the Protein
Target 1 ( High affinity choline transporter 1 (CHT) )
Target Type Literature-reported Target